WST (West Pharmaceutical Services, Inc.) is set to announce its Q2'26 results on July 23, before the market opens. The earnings are expected to be disclosed at 6:00 AM ET (10:00 AM UTC).
For Q2'26, revenue estimate is 839.98 million USD with EPS (earnings per share) anticipated at 2.08 USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported766.50 M804.60 M805.00 M844.90 M— | Revenue Estimate726.09 M785.71 M794.89 M780.31 M839.98 M | Revenue Surprise+5.57%+2.40%+1.27%+8.28% | EPS Reported1.841.962.042.13 | EPS Estimate1.511.681.831.682.08 | EPS Surprise+21.92%+16.33%+11.32%+26.94% |